Immunological and Pathological Roles of Siglecs: A Molecular Review
-
By
-
K, Lakshmi
-
Sundararajan, Vino
-
April 27, 2026
-
Clinical Scorecard: The Functions of Siglecs in Immunology and Pathology: A Comprehensive Molecular Overview
At a Glance
| Category | Detail |
|---|
| Condition | Dysregulation of Siglecs linked to various diseases |
| Key Mechanisms | Regulation of immune responses via inhibitory and activating signaling pathways |
| Target Population | Individuals with cancer, autoimmune disorders, inflammatory disorders, neurodegeneration, and infections |
| Care Setting | Clinical and research settings focusing on immunology and pathology |
Key Highlights
- Siglecs modulate innate and adaptive immunity through sialoglycan recognition
- Dysregulation of Siglecs is associated with diverse human diseases
- Key regulatory mechanisms include transcription factors and microRNAs
- Siglecs signal via ITIM-dependent and ITAM/DAP12-associated pathways
- Targeting Siglec glycan axis presents therapeutic opportunities
Guideline-Based Recommendations
Diagnosis
- Assess Siglec expression and function in relevant diseases
Management
- Consider targeting Siglec pathways for therapeutic interventions
Monitoring & Follow-up
- Monitor immune response modulation in patients with Siglec dysregulation
Risks
- Potential for immune dysregulation if Siglec pathways are disrupted
Patient & Prescribing Data
Patients with conditions linked to Siglec dysregulation
Therapeutic strategies targeting Siglecs may improve disease outcomes
Clinical Best Practices
- Incorporate Siglec profiling in immunological assessments
- Utilize targeted therapies based on Siglec signaling pathways
Related Resources & Content
